Modelled and measured arsenic exposure around a power station in Slovakia

Applied Geochemistry

Volumn 27, Issue 5, 2012, Pages 1013-1019

  Keegan, T J ^a   Nieuwenhuijsen, M J ^b   Pesch, B ^c   Ranft, U ^d   Thornton, I ^e  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b Barcelona Biomedical Research Park   (Spain)

^c INSTITUT DER RUHR UNIVERSITÄT BOCHUM IPA   (Germany)

^d IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC EXPOSURE; ARSENIC UPTAKE; EPIDEMIOLOGICAL STUDIES; EXPOSURE ASSESSMENT; MISCLASSIFICATIONS; POWER STATION; SKIN CANCERS; SLOVAKIA; URINARY ARSENIC;

ARSENIC; DERMATOLOGY; ENVIRONMENTAL PROTECTION AGENCY; PHYSIOLOGY; POWER PLANTS;

CHEMICAL CONTAMINATION;

ABSORPTION; ARSENIC; BIOMARKER; CANCER; EPIDEMIOLOGY; EXCRETION; HEALTH RISK; PHYSIOLOGY; POLLUTION EFFECT; POLLUTION EXPOSURE; POWER PLANT; PUBLIC HEALTH; SKIN DISORDER; SPATIOTEMPORAL ANALYSIS;

SLOVAKIA;

EID: 84859109827     PISSN: 08832927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apgeochem.2011.11.006     Document Type: Article

References (32)

1. Altman D.G. Practical Statistics for Medical Research 1992, Chapman and Hall, London.
2. Bencko V., Rames J., Gotzl M. Preliminary incidence in skin basiloma patients exposed to arsenic in environmental and occupational settings. Arsenic Exposure and Health Effects 1999, Elsevier Science. W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.).
3. Berglund M., Lind B., Lannero E., Vahter M. A pilot study of lead and cadmium exposure in young children in Stockholm, Sweden: methodological considerations using capillary blood microsampling. Arch. Environ. Contam. Toxicol. 1994, 27(2):281-287.
4. Boyce C.P., Lewis A.S., Sax S.N., Eldan M., Cohen S.M., Beck B.D. Probabilistic analysis of human health risks associated with background concentrations of inorganic arsenic: use of a margin of exposure approach. Hum. Ecol. Risk Assess. Int. J. 2008, 14(6):1159-1201.
5. Buchet J.P., Roels H., Lauwerys R., Bruaux P., Claeys-Thoreau F., Lafontaine A., Verduyn G. Repeated surveillance of exposure to cadmium, manganese, and arsenic in school-age children living in rural, urban, and nonferrous smelter areas in Belgium. Environ. Res. 1980, 22(1):95-108.
6. Calabrese E.J., Stanek E.J. An improved method for estimating soil ingestion in children and adults. J. Environ. Sci. Health A - Environ. Sci. Eng. Toxic Hazard. Subst. Control 1993, 28(2):363-371.
7. Colvile R.N., Stevens E.C., Nieuwenhuijsen M.J., Keegan T.J. Atmospheric dispersion modeling for assessment of exposure to arsenic for epidemiological studies in the Nitra Valley, Slovakia. J. Geophys. Res. 2001, 106(D15):17-42.
8. Concha G., Vogler G., Lezcano D., Nermell B., Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 1998, 44(2):185-190.
9. Dor F., Empereur-Bissonnet P., Zmirou D., Nedellec V., Haguenoer J.M., Jongeneelen F., Person A., Dab W., Ferguson C. Validation of multimedia models assessing exposure to PAHs - The SOLEX study. Risk Anal. 2003, 23(5):1047-1057.
10. Enterline P.E., Day R., Marsh G.M. Cancers related to exposure to arsenic at a copper smelter. Occup. Environ. Med. 1995, 52(1):28-32.
11. Ewers U., Wittsiepe J., Hens Bischoff G., Balzer W., Alger B., Urban U. Human biomonitoring - studies of arsenic, lead and PCDD/F in inhabitants of a contaminated residential area. Gesundheitswesen 1997, 59(1):41-50.
12. Fabianova E. PHARE Project Final Report 1995, Specialised State Institute, Banska Bystrica, Bojnice.
13. Garland M., Morris J.S., Rosner B.A., Stampfer M.J., Spate V.L., Baskett C.J., Willett W.C., Hunter D.J. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol. Biomark. Prev. 1993, 2(5):493-497. (published erratum appears in Cancer Epidemiol. Biomark. Prev. 1994; 3(6): 523).
14. Guo H.R., Lipsitz S.R., Hu H., Monson R.R. Using ecological data to estimate a regression model for individual data: the association between arsenic in drinking water and incidence of skin cancer. Environ. Res. 1998, 79(2):82-93.
15. Hwang Y.H., Bornschein R.L., Grote J., Menrath W., Roda S. Environmental arsenic exposure of children around a former copper smelter site. Environ. Res. 1997, 72(1):72-81.
16. Karagas M.R., Stukel T.A., Morris J.S., Tosteson T.D., Weiss J.E., Spencer S.K., Greenberg E.R. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 2001, 153(6):559-565.
17. Karagas M.R., Tosteson T.D., Blum J., Klaue B., Weiss J.E., Stannard V., Spate V., Morris J.S. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am. J. Epidemiol. 2000, 152(1):84-90.
18. Keegan T., Hong B., Thornton I., Farago M., Jakubis P., Jakubis M., Pesch B., Ranft U., Nieuwenhuijsen M.J. Assessment of environmental arsenic levels in Prievidza District. J. Expo. Anal. Environ. Epidemiol. 2002, 12(3):179-185.
19. Nieuwenhuijsen M.J., Pesch B., Ranft U., Farago Margaret E., Thornton I., Keegan T., Jakubis M., Jakubis P., Bencko V. Exposure to Arsenic and Cancer Risks in Central and Eastern Europe (EXPASCAN) 2000, EU, Brussels.
20. Pesch B., Ranft U., Jakubis P., Nieuwenhuijsen M.J., Hergemoller A., Unfried K., Jakubis M., Miskovic P., Keegan T. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: results from a case-control study in the district of Prievidza, Slovakia. Am. J. Epidemiol. 2002, 155(9):798-809.
21. Plesko I., Severi G., Obsitnikova A., Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Neoplasma 2000, 47(3):137-142.
22. Ranft U., Miskovic P., Pesch B., Jakubis P., Fabianova E., Keegan T., Hergemöller A., Jakubis M., Nieuwenhuijsen M.J. Association between arsenic exposure from a coal-burning power plant and urinary arsenic concentrations in Prievidza District, Slovakia. Environ Health Perspect 2003, 111(7):889-894. the EXPASCAN study group.
23. Roberts S.M., Weimar W.R., Vinson J.R., Munson J.W., Bergeron R.J. Measurement of arsenic bioavailability in soil using a primate model. Toxicol. Sci. 2002, 67(2):303-310.
24. Slovenske Elekrarne, 2010. Slovenske Elekrarne Power Plants; Novaky TPP. (retrieved 07.12.10). http://www.seas.sk/en/power-plants/fuel-type/thermal/novaky-tpp.
25. Stanek E.J., Calabrese E.J., Barnes R.M., Danku J.M., Zhou Y., Kostecki P.T., Zillioux E. Bioavailability of arsenic in soil: pilot study results and design considerations. Hum. Exp. Toxicol. 2010, 29(11):945-960.
26. US EPA, 1989a. Exposure Factors Handbook, EPA/600/8-89/043. Office of Health and Environmental Assessment, Environmental Protection Agency, Research Triangle Park, NC.
27. US EPA, 1989b. Risk Assessment Guidance for Superfund, vol. 1. Human Health Evaluation Manual. OSWER Directive 9285.7-01a. Environmental Protection Agency, Washington, DC.
28. Walker S., Griffin S. Site-specific data confirm arsenic exposure predicted by the US Environmental Protection Agency. Environ. Health Perspect. 1998, 106(3):133-139.
29. Wang C.T. Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages. Eur. J. Clin. Chem. Clin. Biochem. 1996, 34(6):493-497.
30. Wong O., Whorton M.D., Foliart D.E., Lowengart R. An ecologic study of skin cancer and environmental arsenic exposure. Int. Arch. Occup. Environ. Health 1992, 64(4):235-241.
31. Xue J., Zartarian V., Wang S., Georgopoulos P. Model estimates of arsenic exposure and dose and evaluation with 2003 NHANES data. Epidemiology 2008, 19(6):S113.
32. Xue J., Zartarian V., Wang S.W., Liu S.V., Georgopoulos P. Probabilistic modeling of dietary arsenic exposure and dose and evaluation with 2003-2004 NHANES data. Environ. Health Perspect. 2009, 118(3):345-350.